Effects of Photobiomodulation in Hemophilia Patients.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-14
SponsorRiphah International University
About this trial
Hemophilia is a genetic bleeding disorder that commonly leads to knee hemarthrosis, causing pain, swelling, and reduced joint mobility in children. While standard treatments include clotting factor replacement and physiotherapy, additional non-invasive approaches are being explored. This study aims to evaluate the effects of photobiomodulation on knee hemarthrosis in male hemophilia patients aged 9-14 years. It focuses on determining whether this therapy can reduce pain and swelling and improve joint range of motion when used alongside
Eligibility criteria
Qualifiers
Hemophilia patients with knee hemarthosis
Patients of age 9-14 yrs will be taken
Bothmaleand female population will be included
Disqualifiers
Presence of open wounds at or near the treatment site.
Kneejoint subluxation.
Presence of congenital or acquired skeletal deformities.
Children diagnosed with cardiopulmonary dysfunctions.
Trial design
Treatments tested in this trial
- photobiomodulation
Treatment groups
24 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov